LGD-3303
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| Routes of administration |
By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C16H14ClF3N2O |
| Molar mass | 342.75 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
LGD-3303 is a drug which acts as a selective androgen receptor modulator (SARM), with good oral bioavailability. It is a selective agonist for the androgen receptor, producing functional selectivity with effective dissociation of anabolic and androgenic effects, acting as a partial agonist for androgenic effects, but a full agonist for anabolic effects. It has been investigated as a possible treatment for osteoporosis, and was shown in animal studies to enhance the effectiveness of a bisphosphonate drug.